✦ LIBER ✦

Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

✍ Scribed by Messori, Andrea; Fadda, Valeria; Maratea, Dario; Trippoli, Sabrina; Marinai, Claudio

Book ID: 125384422
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 372 KB
Volume: 5
Category: Article
ISSN: 1869-6953
DOI: 10.1007/s13300-014-0066-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioglitazone as monotherapy or in combin

Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes

✍ Tan, Meng H.; Glazer, N. Bradly; Johns, Don; Widel, Mario; Gilmore, Kathryn J. 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 318 KB

Efficacy and safety of vildagliptin, Sax

Efficacy and safety of vildagliptin, Saxagliptin or Sitagliptin as add-on therapy in Chinese patients with type 2 diabetes inadequately controlled with dual combination of traditional oral hypoglycemic agents

✍ Li, Chun-Jun; Liu, Xiao-Juan; Bai, Lian; Yu, Qian; Zhang, Qiu-Mei; Yu, Pei; Yu, 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 380 KB

P0583 SAXAGLIPTIN EITHER AS ADD-ON THERA

P0583 SAXAGLIPTIN EITHER AS ADD-ON THERAPY TO METFORMIN OR AS INITIAL COMBINATION THERAPY WITH METFORMIN IMPROVES GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES

✍ Irina Gurieva; Andreas Pfützner; Mikhail Antsiferov; Elsie Allen; Shoba Ravichan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Effect of saxagliptin as add-on therapy

Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin

✍ Barnett, Anthony H.; Charbonnel, Bernard; Donovan, Mark; Fleming, Douglas 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 379 KB

The effect of initial therapy with the f

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

✍ C. Reasner; L. Olansky; T. L. Seck; D. E. Williams-Herman; M. Chen; L. Terranell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

Improvement in glycaemic control β-cell

Improvement in glycaemic control β-cell function over 2 years with sitagliptin as monotherapy or add-on therapy to metformin in patients with type 2 diabetes

✍ Williams-Herman, D.; Seck, T.; Golm, G.; Wang, H.; Johnson, J.; Kaufman, K.D.; G 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 435 KB